AU7241281A – Compounds of mucolytic activity
– Google Patents
AU7241281A – Compounds of mucolytic activity
– Google Patents
Compounds of mucolytic activity
Info
Publication number
AU7241281A
AU7241281A
AU72412/81A
AU7241281A
AU7241281A
AU 7241281 A
AU7241281 A
AU 7241281A
AU 72412/81 A
AU72412/81 A
AU 72412/81A
AU 7241281 A
AU7241281 A
AU 7241281A
AU 7241281 A
AU7241281 A
AU 7241281A
Authority
AU
Australia
Prior art keywords
compounds
mucolytic activity
mucolytic
activity
proups
Prior art date
1980-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72412/81A
Inventor
Javier Esteban Maltz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texcontor
Original Assignee
Texcontor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-07-01
Filing date
1981-06-30
Publication date
1982-01-07
1981-06-30
Application filed by Texcontor
filed
Critical
Texcontor
1982-01-07
Publication of AU7241281A
publication
Critical
patent/AU7241281A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/43—Enzymes; Proenzymes; Derivatives thereof
A61K38/46—Hydrolases (3)
A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/10—Expectorants
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
C12N11/087—Acrylic polymers
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Y—ENZYMES
C12Y301/00—Hydrolases acting on ester bonds (3.1)
C12Y301/21—Endodeoxyribonucleases producing 5′-phosphomonoesters (3.1.21)
C12Y301/21001—Deoxyribonuclease I (3.1.21.1)
Abstract
Macromolecular compounds of mucolytic activity, non-absorbable by tissues, free from side-effects, compatible with antibiotics, and constituted by carbohydrates as their basic structure, to which proteolytic enzymes and sulphydryl proups are bonded by suitable aliphatic chains.
AU72412/81A
1980-07-01
1981-06-30
Compounds of mucolytic activity
Abandoned
AU7241281A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
IT8023161A
IT1209419B
(en)
1980-07-01
1980-07-01
COMPOUNDS WITH NON-SIMILAR MUCOLITICAL ACTIVITIES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT INCLUDE THEM AS AN ACTIVE INGREDIENT.
IT2316180
1980-07-01
Publications (1)
Publication Number
Publication Date
AU7241281A
true
AU7241281A
(en)
1982-01-07
Family
ID=11204417
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU72412/81A
Abandoned
AU7241281A
(en)
1980-07-01
1981-06-30
Compounds of mucolytic activity
Country Status (11)
Country
Link
US
(2)
US4409138A
(en)
EP
(1)
EP0045285B1
(en)
JP
(1)
JPS5813522A
(en)
AT
(1)
ATE7202T1
(en)
AU
(1)
AU7241281A
(en)
CA
(1)
CA1168169A
(en)
DE
(1)
DE3163287D1
(en)
ES
(1)
ES503527A0
(en)
FR
(1)
FR2485925A1
(en)
IT
(1)
IT1209419B
(en)
YU
(1)
YU163681A
(en)
Families Citing this family (7)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU574360B2
(en)
*
1983-05-13
1988-07-07
Reichert, D.
Antisnoring agent
US4585754A
(en)
*
1984-01-09
1986-04-29
Valcor Scientific, Ltd.
Stabilization of proteins and peptides by chemical binding with chondroitin
CA1317860C
(en)
*
1987-04-01
1993-05-18
Daniel Louis Kacian
Techniques for preparing specimens for bacterial assays
US5128132A
(en)
*
1988-11-22
1992-07-07
Parnell Pharmaceuticals, Inc.
Eriodictyon compositions and methods for treating internal mucous membranes
WO2003003976A2
(en)
*
2001-07-03
2003-01-16
Alcon, Inc.
Compositions for removing human cerumen
US20060182705A1
(en)
*
2005-02-11
2006-08-17
Cruse Maria K
Composition for reduction and prevention of wrinkles on the skin
EP3797783A1
(en)
2019-09-27
2021-03-31
Freie Universität Berlin
Novel medical uses of thiol-functionalized polyglycerol derivatives
Family Cites Families (12)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
FR924877A
(en)
*
1946-03-15
1947-08-19
Manufacturing process of veterinary preparations
US4004979A
(en)
*
1968-03-29
1977-01-25
Agence Nationale De Valorisation De La Recherche (Anvar)
Preparation of active proteins cross-linked to inactive proteins
NL6812443A
(en)
*
1968-08-31
1970-03-03
BE758425A
(en)
*
1969-12-02
1971-04-16
Baxter Laboratories Inc
STREPTOKINASE CHEMICALLY LINKED TO A CARBOHYDRATE MATRIX (
US3683069A
(en)
*
1970-02-19
1972-08-08
Michel Hooreman
Enzymatic products which optimize the viscosity of mucuses and their applications
JPS5443074B1
(en)
1971-04-14
1979-12-18
BE790326A
(en)
*
1971-10-20
1973-04-19
Pechiney Ugine Kuhlmann
NEW HYDROXYQUINOLEINE DERIVATIVE
US4185090A
(en)
*
1972-02-02
1980-01-22
Abbott Laboratories
Chemically modified endotoxin immunizing agent
GB1479268A
(en)
*
1973-07-05
1977-07-13
Beecham Group Ltd
Pharmaceutical compositions
SE431758B
(en)
*
1977-03-04
1984-02-27
Pharmacia Fine Chemicals Ab
AS THE USE OF THE TIOLATION REAGENT OR BERRY MATRIX FOR ENZYMERS DERIVATIVE OF A SH GROUPING POLYMER
CS204190B1
(en)
*
1978-02-22
1981-03-31
Jaroslav Drobnik
Activation method for hydrxyl groups containing insoluble carriers
US4259233A
(en)
*
1979-10-23
1981-03-31
Miles Laboratories, Inc.
β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates
1980
1980-07-01
IT
IT8023161A
patent/IT1209419B/en
active
1980-08-11
FR
FR8017656A
patent/FR2485925A1/en
active
Granted
1980-09-05
US
US06/184,249
patent/US4409138A/en
not_active
Expired – Lifetime
1981
1981-06-19
EP
EP81830099A
patent/EP0045285B1/en
not_active
Expired
1981-06-19
DE
DE8181830099T
patent/DE3163287D1/en
not_active
Expired
1981-06-19
AT
AT81830099T
patent/ATE7202T1/en
not_active
IP Right Cessation
1981-06-29
CA
CA000380788A
patent/CA1168169A/en
not_active
Expired
1981-06-30
ES
ES503527A
patent/ES503527A0/en
active
Granted
1981-06-30
AU
AU72412/81A
patent/AU7241281A/en
not_active
Abandoned
1981-07-01
YU
YU01636/81A
patent/YU163681A/en
unknown
1981-07-01
JP
JP56101394A
patent/JPS5813522A/en
active
Pending
1983
1983-07-11
US
US06/512,679
patent/US4559322A/en
not_active
Expired – Fee Related
Also Published As
Publication number
Publication date
FR2485925B1
(en)
1985-05-24
US4559322A
(en)
1985-12-17
FR2485925A1
(en)
1982-01-08
EP0045285A1
(en)
1982-02-03
DE3163287D1
(en)
1984-05-30
ES8203420A1
(en)
1982-04-01
ATE7202T1
(en)
1984-05-15
EP0045285B1
(en)
1984-04-25
US4409138A
(en)
1983-10-11
IT1209419B
(en)
1989-07-16
YU163681A
(en)
1983-09-30
JPS5813522A
(en)
1983-01-26
ES503527A0
(en)
1982-04-01
IT8023161D0
(en)
1980-07-01
CA1168169A
(en)
1984-05-29
Similar Documents
Publication
Publication Date
Title
ATE62249T1
(en)
1991-04-15
HOMODISACCHARID HYPOGLYCEMIC AGENT.
NL191308B
(en)
1994-12-16
Lyophilized post-solution injectable preparation containing an anthracycline glycoside and process for the preparation of an injectable solution of an anthracycline glycoside.
IE45524L
(en)
1978-01-12
Complement inhibitors
PL322681A1
(en)
1998-02-16
Cytostatic agents modified with carbohydrates
SE8202439L
(en)
1983-10-20
4'-IODINE DERIVATIVES OF ANTRACYCLING GYCOSIDES
AU7241281A
(en)
1982-01-07
Compounds of mucolytic activity
NO173043B
(en)
1993-07-12
ANTI-DENATURING AGENT FOR ADDING TO A EDIBLE POSTAGE PRODUCT.
AU8213487A
(en)
1988-06-09
Anthracycline derivatives having cytostatic activity
IE801891L
(en)
1981-03-10
4-alkyl-8-aminoalkylpsoralens
FR2406639A1
(en)
1979-05-18
DESOXYNARASIN ANTIBIOTICS AND THEIR THERAPEUTIC USES
IE40384L
(en)
1974-11-10
Aminoglycosides
GB1404516A
(en)
1975-08-28
Stabilization of microorganism cells lytic enzyme
IE42052L
(en)
1976-03-20
Acylated orgotein
JPH0575384B2
(en)
1993-10-20
IE780205L
(en)
1978-08-01
Insulin-secretion promoting protein.
JPS523892A
(en)
1977-01-12
Method of enzyme immobilization
CA2066234A1
(en)
1991-04-27
Activation compounds and methods for nucleic acid sterilization
JPS5414513A
(en)
1979-02-02
Novel composition
IE780623L
(en)
1978-09-28
Antimicrobial composition
EP0310410A3
(en)
1990-01-17
Control of calcium activated potassium efflux from injured body cells
JPS5264494A
(en)
1977-05-27
Preparation of fr-1923 substance
IE38688L
(en)
1974-01-19
Purification of orgotein
ES508646A0
(en)
1983-04-16
FERMENTATION PROCEDURE TO PRODUCE CUZINS, ORGANIC ACIDS, ANTIBIOTICS, POLYSACCHARIDES, AMINATE ACIDS AND VITAMINS.
JPS5257392A
(en)
1977-05-11
Immobilized enzyme using fibroin as carrier and method of preparing th e same
JPS53130486A
(en)
1978-11-14
Preparation of immobilized enzyme
None